Fig. 1
From: Quality of radiotherapy reporting in randomized controlled trials of prostate cancer
Bias in reporting of toxicity endpoint assessment was explored using a hierarchy scale from 1 (excellent) to 7 (very poor) to indicate whether reporting of toxicities occurred in the abstract, discussion, concluding statement or results table (Fig. 1). Reports with scores 5 to 7 were judged as having bias in the reporting of toxicity endpoint
